Cognos

Cognos Therapeutics is a medical technology company developing advanced drug delivery systems designed to treat neurological diseases and solid tumors. The company's core technology, the Sinnais Implantable Pump, is a smart, programmable device capable of delivering drugs directly to the brain or other specific organs, effectively bypassing the blood-brain barrier. This localized delivery method is intended to maximize therapeutic concentrations at the disease site while reducing systemic side effects. Cognos is currently focusing on high-mortality conditions such as glioblastoma multiforme and leptomeningeal carcinomatosis. The company aims to transform the standard of care for cancers that are currently difficult to treat due to physiological barriers.